-
U.S. Food And Drug Administration Approves CSL's ANDEMBRY® (Garadacimab-Gxii), The Only Prophylactic Hereditary Angioedema (HAE) Treatment Targeting Factor Xiia With Once-Monthly Dosing For All Patients From The Start
17 Jun 2025 01:04 GMT
… the U.S. Food and Drug Administration (FDA) approved ANDEMBRY® … at the CSL Broadmeadows Biotech Manufacturing Facility. ANDEMBRY uniquely … negative side effects of prescription drugs to the FDA. Visit … CSLLY) is a global biotechnology company with a dynamic …
-
About 100 Korean Pharmaceutical and Biotech Firms Attend Bio 2025 in Boston
17 Jun 2025 02:12 GMT
Domestic pharmaceutical and biotech companies are gearing up … and its newly launched antibody-drug conjugate (ADC) services. … generation ADCs and novel antibody drugs. The company will also … will introduce their novel drug development status and open …
-
South Korea faces setback in drug development race
16 Jun 2025 23:45 GMT
… re-evaluations of some drugs. Industry experts warn that … and contribute significantly to drug development. In 2024, … trials, medical research, and drug development are closely connected. … growth engines such as biotechnology and pharmaceuticals. China’s …
-
[BIO USA 2025] KoreaBIO VP warns time is running out for Korea to secure global biotech leadership
17 Jun 2025 02:16 GMT
… advancing competitors, according to Korea Biotechnology Industry Organization (KoreaBIO) Vice President … capable of delivering globally competitive drug pipelines.
At a recent global … Korea’s expanding role across drug discovery, clinical development, and …
-
Eli Lilly nears $1.3B deal for gene-editing biotech Verve Therapeutics
17 Jun 2025 00:07 GMT
… Times reported on Monday. The drug maker's acquisition bid … used in combination with other drugs. Lilly Biotechnology Center is shown in …
-
[Photo News] Korean biotech firms take center stage at BIO USA 2025 in Boston
17 Jun 2025 00:45 GMT
… More than 80 Korean pharmaceutical, biotech, and research institutions are … topics from AI-driven drug development to global biotech investment strategies.
Notably … new drug development, cell and gene therapy, clinical trial services, biotech platforms …
-
Biotech Player CSL Gains FDA Nod for Rare Genetic Disorder Therapy
17 Jun 2025 01:40 GMT
… in rare disease therapies
Global biotechnology leader CSL (ASX:CSL), part … therapeutics. The US Food and Drug Administration (FDA) has granted approval … its standing as a key biotech innovator, bringing hope to patients …
-
Beleaguered Biotech Snapped Up In $561 Million Bid
16 Jun 2025 20:53 GMT
… ) agreed Monday to buy beleaguered biotech Sage Therapeutics (SAGE) in a … had hoped the Food and Drug Administration would sign off on … the drug as a treatment for major … . Sage has also had multiple drugs fail in testing as treatments …
-
Dr Boreham’s Crucible: Sizing up the opportunity for ASX biotech Adherium
16 Jun 2025 20:19 GMT
… , it won US Food and Drug Administration (FDA) clearance under the … the clinical benefit of the drug.”
Crucially, Hailie can also detect … and exhales, but finds watching biotech stocks can be an exercise …
This content originally appeared in Biotech Daily.
-
Sarepta Crashes After Second Death On Gene Therapy Drug
16 Jun 2025 18:54 GMT
… following treatment with Elevidys, the biotech';s one-time gene … will intensify the Food and Drug Administration's scrutiny of …